These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11030058)

  • 1. [Genetic evolution under vaccine pressure: the Bordetella pertussis model].
    Simondon F; Guiso N
    Bull Soc Pathol Exot; 2000 Jul; 93(3):202-5. PubMed ID: 11030058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?
    Godfroid F; Denoël P; Poolman J
    Expert Rev Vaccines; 2005 Oct; 4(5):757-78. PubMed ID: 16221076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen.
    Mooi FR
    Infect Genet Evol; 2010 Jan; 10(1):36-49. PubMed ID: 19879977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of vaccination on the infectious diseases epidemiology: example of pertussis].
    Guiso N
    Med Sci (Paris); 2007 Apr; 23(4):399-403. PubMed ID: 17433230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.
    Preston A
    Hum Vaccin Immunother; 2016 May; 12(5):1274-6. PubMed ID: 26889694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).
    Ward JI; Cherry JD; Chang SJ; Partridge S; Keitel W; Edwards K; Lee M; Treanor J; Greenberg DP; Barenkamp S; Bernstein DI; Edelman R;
    Clin Infect Dis; 2006 Jul; 43(2):151-7. PubMed ID: 16779740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis in Argentina and France.
    Caro V; Bouchez V; Guiso N; Gatti B; Agosti MR; Ayala SE
    Vaccine; 2007 May; 25(22):4335-9. PubMed ID: 17229502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories.
    Elomaa A; Advani A; Donnelly D; Antila M; Mertsola J; He Q; Hallander H
    Vaccine; 2007 Jan; 25(5):918-26. PubMed ID: 17030495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence.
    Sealey KL; Belcher T; Preston A
    Infect Genet Evol; 2016 Jun; 40():136-143. PubMed ID: 26932577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pertussis vaccine in adolescents and adults].
    Lévy J; Swennen B; Van Laethem Y
    Rev Med Brux; 2004 Sep; 25(4):A229-32. PubMed ID: 15516047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection.
    Octavia S; Maharjan RP; Sintchenko V; Stevenson G; Reeves PR; Gilbert GL; Lan R
    Mol Biol Evol; 2011 Jan; 28(1):707-15. PubMed ID: 20833694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis control: time for something new?
    Clark TA; Messonnier NE; Hadler SC
    Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Restriction analysis of Bordetella pertussis DNA isolated from patients with whooping cough in 1968 and 1995-98 and B. pertussis used for production of national vaccine strains].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 2000; 52(2):111-7. PubMed ID: 11107785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis vaccines: present status.
    Christodoulides M
    Adv Biotechnol Processes; 1990; 13():169-99. PubMed ID: 2185783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic variability of Bordetella pertussis strains. Part II. Perspectives].
    Gzyl A; Augustynowicz E; Gniadek G; Slusarczyk J
    Przegl Epidemiol; 2003; 57(1):193-200. PubMed ID: 12926328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany.
    Juretzko P; von Kries R; Hermann M; Wirsing von König CH; Weil J; Giani G
    Clin Infect Dis; 2002 Jul; 35(2):162-7. PubMed ID: 12087522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pertussis: a reemerging infection?].
    Kriz B; Fabiánová K; Maixnerová M; Benes C; Malý M
    Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):51-65. PubMed ID: 17593802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
    Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
    Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.